Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
LCTX:TLV
Lineage Cell Therapeutics Inc
442,70 ILA
0,00%
(0,00) 1D
1 may, 13:44:20 GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for LCTX...
Açın
442,70 ILA
High
442,70 ILA
Low
442,70 ILA
Mkt. cap
381,43 mln
Avg. vol.
3,80K
Volume
8,00
52-wk high
666,00 ILA
52-wk low
150,30 ILA
Shares outstanding
249,09 mln
No. of employees
75
News stories
From sources across the web
Profile
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
About Lineage Cell Therapeutics Inc
CEO-
Employees75
Founded1990
Headquarters-
Sector-
Websitelineagecell.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
1,50 mln
2,76 mln
3,68 mln
6,61 mln
Cost of goods sold
2,98 mln
3,14 mln
184,00K
17,26 mln
Cost of revenue
2,98 mln
3,14 mln
184,00K
17,26 mln
Research and development expenses
169,00K
-
3,09 mln
-8,96 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,86 mln
4,56 mln
4,19 mln
4,85 mln
Operating expense
5,03 mln
4,56 mln
7,28 mln
-4,11 mln
Total operating expenses
8,01 mln
7,70 mln
7,47 mln
13,16 mln
Operating income
-6,50 mln
-4,94 mln
-3,79 mln
-6,55 mln
Other non operating income
2,12 mln
-12,71 mln
-26,56 mln
1,29 mln
EBT including unusual items
-4,14 mln
-30,36 mln
-29,75 mln
-4,39 mln
EBT excluding unusual items
-4,14 mln
-15,52 mln
-29,76 mln
-4,38 mln
Income tax expense
-
-
-
-5,28 mln
Effective tax rate
-
-
-
120,33%
Other operating expenses
-
-
-
-
Net income
-4,14 mln
-30,46 mln
-29,78 mln
851,00K
Net profit margin
-275,57%
-1.101,77%
-809,05%
12,88%
Earnings per share
-0,02
-0,13
-0,13
-
Interest and investment income
478,00K
454,00K
366,00K
393,00K
Interest expense
-
-
-
-
Net interest expenses
478,00K
454,00K
366,00K
393,00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,34 mln
-4,77 mln
-3,61 mln
-6,36 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer